AMRZ Form 4: Chief Supply Chain Officer Raises Stake to 20,232 Shares
Rhea-AI Filing Summary
Mario Gross, Chief Supply Chain Officer of Amrize Ltd (AMRZ), reported two open-market purchases of ordinary shares. The filings show purchases of 5,000 shares on 08/08/2025 and 2,600 shares on 08/11/2025, executed in Swiss francs and converted to U.S. dollars at the stated exchange rates. The reported USD-equivalent prices were $46.78 and $47.75 per share. After these transactions Gross beneficially owned 20,232 shares. The Form 4 discloses the transaction codes as purchases and includes conversion details for transparency.
The filing contains only non-derivative purchases and a manual signature by an attorney-in-fact; no options, dispositions, or other compensatory awards are reported.
Positive
- Insider purchases disclosed: Officer acquired a total of 7,600 ordinary shares in two transactions, indicating insider buying activity.
- Detailed currency conversion provided: Purchases executed in CHF include explicit exchange rates and USD-equivalent prices, improving disclosure transparency.
Negative
- None.
Insights
TL;DR: Insider purchases totaling 7,600 shares increase disclosed ownership to 20,232 shares; modestly informative but likely not market-moving.
The Form 4 documents two open-market purchases: 5,000 shares at an effective USD price of $46.78 and 2,600 shares at $47.75, for a total of 7,600 shares acquired. While insider buying can signal confidence, the filing provides no context on company float or market capitalization, limiting assessment of materiality. The disclosure is complete for non-derivative activity and includes currency conversion details, aiding transparency.
TL;DR: Filing appears procedurally correct and transparent; transactions were purchased in CHF and properly converted to USD.
The Form 4 identifies the reporting person, role (Chief Supply Chain Officer), transaction codes indicating purchases, and post-transaction beneficial ownership. Conversion rates for CHF-to-USD are provided for each trade, and an attorney-in-fact signed the form. No derivative transactions or compensatory share grants are reported. From a compliance and disclosure standpoint the document meets Section 16 transparency requirements for these trades.
FAQ
What did Amrize (AMRZ) insider Mario Gross report on Form 4?
At what prices were the AMRZ shares purchased?
How many AMRZ shares does Mario Gross own after these transactions?
Were any derivative securities reported for AMRZ in this filing?
When were the AMRZ transactions executed?